| Title | Clinical and Translational Discovery |
| Abbreviation | Clin. Transl. Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cell Biology (Q4); Clinical Biochemistry (Q4); Genetics (Q4); Molecular Medicine (Q4) |
| h-index | 5 |
| Overall Rank/Ranking | 16700 |
| SCImago Journal Rank (SJR) | 0.271 |
| Impact Score | 0.60 |
| Publisher | Blackwell Publishing |
| Country | Denmark |
| ISSN | 27680622 |
| Best Quartile | Q4 |
| Coverage History | 2021-2023 |
Clinical and Translational Discovery is a journal covering the technologies/fields/categories related to Cell Biology (Q4); Clinical Biochemistry (Q4); Genetics (Q4); Molecular Medicine (Q4). It is published by Blackwell Publishing. The overall rank of Clinical and Translational Discovery is 16700. According to SCImago Journal Rank (SJR), this journal is ranked 0.271. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 5. The best quartile for this journal is Q4.
The ISSN of Clinical and Translational Discovery journal is 27680622. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical and Translational Discovery is cited by a total of 84 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Clinical and Translational Discovery is 0.60, which is computed in 2024 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Clinical and Translational Discovery is 0.60. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.60 |
Clinical and Translational Discovery has an h-index of 5. It means 5 articles of this journal have more than 5 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical and Translational Discovery is 27680622. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical and Translational Discovery is 16700. According to SCImago Journal Rank (SJR), this journal is ranked 0.271. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.271 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 16700 |
Clinical and Translational Discovery is published by Blackwell Publishing. It's publishing house is located in Denmark. Coverage history of this journal is as following: 2021-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical and Translational Discovery is Clin. Transl. Discov.. This abbreviation ('Clin. Transl. Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cell Biology (Q4); Clinical Biochemistry (Q4); Genetics (Q4); Molecular Medicine (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical and Translational Discovery latest impact IF is 0.60. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 0.60 (2023) and 0.60 (2023), respectively, in the last 1 year. Moreover, its average IS is 0.6 in the previous 1 year.
The Clinical and Translational Discovery has an SJR (SCImago Journal Rank) of 0.271, according to the latest data. It is computed in the year 2024. In the past 1 years, this journal has recorded a range of SJR, with the highest being 0.271 in 2023 and the lowest being 0.271 in 2023. Furthermore, the average SJR of the Clinical and Translational Discovery over the previous 1-year period stands at 0.6.
The latest h-index of the Clinical and Translational Discovery is 5.
The Clinical and Translational Discovery is published by the Blackwell Publishing, with its country of publication being the Denmark.
The Clinical and Translational Discovery is currently ranked 16700 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 1 year, this journal has experienced varying rankings, reaching its highest position of 16700 in 2023 and its lowest position of 16700 in 2023.
The standard ISO4 abbreviation for the Clinical and Translational Discovery is Clin. Transl. Discov..
Clinical and Translational Discovery is classified as a journal that the Blackwell Publishing publishes.
The Clinical and Translational Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical and Translational Discovery is assigned the following International Standard Serial Numbers (ISSN): 27680622.
The best quartile for the Clinical and Translational Discovery is Q4 (2023).
The Clinical and Translational Discovery coverage history can be summarized as follows: 2021-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Clinical Medicine and Research | journal | 14722 | Marshfield Clinic | 62 | 1.02 |
| Journal of Supply Chain Management | journal | 587 | Wiley-Blackwell | 112 | 12.51 |
| Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
| Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
| Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18870 | Springer Medizin | 24 | 0.60 |
| Tekstilec | trade journal | 18966 | University of Ljubljana Press | 15 | 0.91 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.60 |
